In vivo methods for evaluation of drugs for the treatment of gastrointestinal motility disorders

Indian Journal of Pharmaceutical Education and Research

Volumn 44, Issue 1, 2010, Pages 42-48

  Peddireddy, M K R ^a  

^a MBARARA UNIVERSITY OF SCIENCE AND TECHNOLOGY   (Uganda)

Author keywords

[No Author keywords available]

Indexed keywords

ATROPINE; CARBACHOL; CHARCOAL; METOCLOPRAMIDE; PHENOLSULFONPHTHALEIN; PROKINETIC AGENT; RADIOACTIVE MATERIAL; SPASMOLYTIC AGENT;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; COLON; COLON MOTILITY; DRUG SAFETY; DRUG SCREENING; ESOPHAGUS ACHALASIA; FLUORESCENCE; GASTROINTESTINAL MOTILITY DISORDER; IN VIVO STUDY; INTESTINE TRANSIT TIME; MOUSE; NONHUMAN; PYLORUS STENOSIS; RADIOLOGY; RAT; SALIVATION; STOMACH; STOMACH EMPTYING; STOMACH MOTILITY; TELEMETRY; TEST MEAL;

EID: 76049095886     PISSN: 00195464     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (21)

1. Macht DI, Barbara-Gose J. Two new methods for pharmacological comparison of insoluble purgatives. J Am Pharm Sci Edu 1931;20:558-564.
2. Janssen AJ, Jageneau AH. A new series of potent analgesics. J Pharm Pharmacol 1957;9:381-400.
3. Purdon RA, Bass P. Gastric and intestinal transit in rats measured by a radioactive test meal. Gastroenterology 1973;64:968-976.
4. Jung KY, Choo YK, Kim HM, Choi BK. Raddish extract stimulates motility of the intestine via the muscarinic receptors. J Pharm Pharmacol 2000;52:1031-1036.
5. Summers RW, Kent TW, Osborne JW. Effect of drugs, ileal obstruction and irradiation on rat gastrointestinal propulsion. Gastroenterology 1970;59:731-739.
6. Miller MS, Galligan JJ, Burks TF. Accurate measurement of intestinal transit in the rat. J Pharmacol Methods 1981;6:211-7.
7. Porreca F, Burks TF. The spinal cord as a site of opioid effects on gastrointestinal transit in the mouse. J Pharmacol Exp Ther 1983;227:22-7.
8. Pohle T, Domschke W. Gastric function measurements in drug development. Br J Clin Pharmacol 2003;56:156-64.
9. Matsuda H, Li Y, Yamahara J, Yoshikawa M. Inhibition of gastric emptying by triterpene saponin, momordin, in mice: roles of blood glucose, capsaicin-sensitive sensory nerves, and central nervous system. J Pharmacol Exp Ther 1999;289:729-734.
10. Droppleman DA, Gregory RL, Alphin RS. A simplified method for assessing drug effects on gastric emptying in rats. J Pharmacol Methods 1980;4:227-230.
11. Vogel HG, Vogel WH. Activity on the gastrointestinal tract. In: Vogel HG, Vogel WH, editors. Drug discovery & Evaluation. Berlin, Springer-Verlag, 1997. p. 461-533.
12. Hamano N, Inada T, Iwata R, Asai T, Shingu K. The alpha2-adrenergic receptor antagonist yohimbine improves endotoxin-induced inhibition of gastrointestinal motility in mice. Br J Anaesth 2007;98:484-90.
13. Bickel M. Stimulation of colonic motility in dogs and rats by an enkephalin analogue pentapeptide. Life Sci 1983; 33 suppl 1: 469-472.
14. Maggi CA, Meli A. Eserine-induced hypertone of guinea pig distal colon in vivo: a new pharmacological procedure for testing smooth muscle relaxants. J Pharmacol Methods 1984;12:91-96.
15. Leng-Peschlow E. Acceleration of large intestine transit time in rats by sennosides and related compounds. J Pharm Pharmacol 1986;38:369-373.
16. Koslo RJ, Burks TF, Porreca F. Centrally administered bombesin affects gastrointestinal transit and colonic bead expulsion through supraspinal mechanisms. J Pharmacol Exp Ther 1986;238:62-67.
17. Wright JW, Healy TE, Balfour TW, Hardcastle JD. A method for long-term recording of intestinal mechanical and electrical activity in the unrestrained rat. J Pharmacol Methods 1981;6:233-242.
18. Szurszewski JH.A migrating electric complex of canine small intestine. Am J Physiol 1969;217:1757-63.
19. Mann PC, Bollman R. A method for making a satisfactory fistula at any level of the gastrointestinal tract. Ana Surg 1931;93:795-797.
20. Tasaka K, Farrar JT. Intraluminal pressure of the small intestine of the unanaesthetized dog. Pflugers Arch 1976;364:35-44.
21. Goldenberg MM, Burns RH. Effectiveness of a unique antispasmodic 3,4-dihydro-5-phenoxybenzo (b)(1,7)naphthyridin-1(2H)-one eu-1086, in vivo and in vitro. Arch Int Pharmacodyn Ther 1973;203:55-66.